Novo Nordisk plans to initiate a new phase IIIa trial program against obesity with the firm's molecule semaglutide, according to a press release on Wednesday afternoon.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
EU Commission proposes staggered transition to new medtech requirements after industry warnings
After criticism for a lack of clarity on the regulation for medtech devices from doctors and industry players, the EU Commission has proposed an extension of the transition period.
New majority owner makes several board appointments at hearing firm
Eargo’s new majority shareholder, Patient Square Capital, is now represented by several board members.
Danish agency joins competition authority chorus in criticizing Oticon Medical sale
The Danish competition authorities are the latest to express concern over the potential sale of Demant’s Oticon Medical division to Cochlear.
Full house for Ambu – all products live up to new EU requirements
Medtech company Ambu can boast that all of its products live up to the MDR directive, which has introduced stricter requirements for medical equipment.
FDA approves new sensor for insulin pens
A new type of sensor which is able to collect and transmit key treatment information has been approved by the FDA.
Consultants for FIERS - will you create unique healthcare collaborations? - FIERS - Copenhagen / Denmark 
Head of Engineering 
Laboratory assistants for an exciting QC department 
Quality Compliance Specialist - Herbal Medicines and Medical Devices 
Systems Verification Manager for Embedded Medical Solutions 
Medical Director 
Chief consultant for Dansk Erhvervs Health and life science 
Associated Director Device Development and Support Global CMC Development, ALK 
Senior or Principal Scientist – Preclinical Biology 
Head of Regulatory Affairs Danmark 
Supply Chain Manager